Tag: drug pricing

Evergreening: How Drug Companies Stretch Patents to Block Generic Competition

Evergreening: How Drug Companies Stretch Patents to Block Generic Competition

6 March 2026

Evergreening lets drug companies extend patent life by making tiny changes to old medicines, blocking cheaper generics and keeping prices high. Learn how it works and why it’s under fire.

learn more
Market Competition: How Multiple Generic Drug Competitors Actually Affect Prices

Market Competition: How Multiple Generic Drug Competitors Actually Affect Prices

15 February 2026

More generic drug competitors don't always mean lower prices. Real-world data shows how patents, PBMs, complex formulations, and regulatory policies distort competition - often keeping prices high despite dozens of approved generics.

learn more
Future Biosimilars: Upcoming Patent Expirations and Market Entry

Future Biosimilars: Upcoming Patent Expirations and Market Entry

1 February 2026

Upcoming patent expirations for blockbuster biologics like Keytruda and Eylea are set to unleash a wave of biosimilars, potentially saving the U.S. healthcare system hundreds of billions. Here’s what’s coming, who’s entering the market, and how it will change patient access.

learn more